Zydus Cadila gets USFDA nod for breast cancer treatment drug

By: |
July 30, 2021 3:28 PM

Fulvestrant injection is used alone or in combination with other drugs to treat a certain type of hormone receptor positive, advanced breast cancer (breast cancer that depends on hormones such as estrogen to grow) or breast cancer that has spread to other parts of the body in women who have experienced menopause.

The company now has three biosimilars including the Denosumab biosimilar drug for osteoporosis and has some more in the pipeline.The company now has three biosimilars including the Denosumab biosimilar drug for osteoporosis and has some more in the pipeline. (Representative image)

Drug firm Zydus Cadila on Friday said it has received final approval from the US health regulator to market Fulvestrant Injection, used in the treatment of breast cancer.

Fulvestrant injection is used alone or in combination with other drugs to treat a certain type of hormone receptor positive, advanced breast cancer (breast cancer that depends on hormones such as estrogen to grow) or breast cancer that has spread to other parts of the body in women who have experienced menopause.

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose pre-filled syringe, the company said in a statement. Zydus Cadila said the drug will be manufactured at the group’s formulation manufacturing facility at Zydus Biologics, Ahmedabad.

The group now has 320 approvals and has so far filed over 400 abbreviated new drug applications (ANDAs) since the commencement of the filing process in FY 2003-04.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1WHO chief thanks Health Minister Mansukh Mandaviya for announcing resumption of COVID-19 vaccine shipments
2”Soul-crushing”: US COVID-19 deaths are topping 1,900 a day
3Black fungus: 3,900 people in Karnataka infected so far